CDK Inhibitors approved by PBAC 20 April 2018
CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue. See the link below for further information https://www.bcna.org.au/news/2018/04/cdk-i...
Forum Discussion
I posted this on the General Discussion board by mistake. This would have been more appropriate.
Can someone tell me how the Palbociclib Access Program works? I'm asking out of interest for women who already have metastatic breast cancer and will be taking it for the rest of their life. It doesn't affect me personally as I'm on a trial and receive Palbociclib free. I'm curious about the eligibility. I believe newly diagnosed women will pay $50 upfront and then receive all scripts for free after that. Does this mean until the drug is listed on the PBS or for life? If newly diagnosed women can receive it for $50 for life, why would those who are already diagnosed have to pay for each script when it is listed? Or am I missing something?
Can someone tell me how the Palbociclib Access Program works? I'm asking out of interest for women who already have metastatic breast cancer and will be taking it for the rest of their life. It doesn't affect me personally as I'm on a trial and receive Palbociclib free. I'm curious about the eligibility. I believe newly diagnosed women will pay $50 upfront and then receive all scripts for free after that. Does this mean until the drug is listed on the PBS or for life? If newly diagnosed women can receive it for $50 for life, why would those who are already diagnosed have to pay for each script when it is listed? Or am I missing something?